Webcast/CME - Considerations in Pharmacy Compounding and the Treatment of Spasticity

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Orthopaedics Other

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Orthopaedics Other

	Update on DVT and PE in OB Gyn/Ortho Patients
	Differential Diagnosis and Management of Autoimmune Neuromuscular Diseases: A Case-Based Approach
	Frailty

Recent news - Orthopaedics Other

	Chronic musculoskeletal pain and the occurrence of falls in an older population - (JAMA)
	Severe Joint Pain in Multiple Areas Associated With Increased Risk of Falls in Older Adults - (DGNews)
	Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
	Surgery Provides Modest Benefit Over Non-Surgical Treatment for Carpal Tunnel Syndrome - (DGNews)
	Denosumab Superior to Zoledronic Acid in Delaying Skeletal-Related Events in Breast Cancer With Bone Metastases: Presented at ECCO-ESMO - (DGDispatch)

Recent cases - Orthopaedics Other

	Closed Total Talus Dislocation Without Fracture: Case Report
	Lung Metastasis 21 Years After Initial Diagnosis Of Osteosarcoma: A Case Report
	Gluteal Compartment Syndrome: A Case Report
	Dynamic Splinting Home Therapy for Toe Walking: A Case Report
	A Stiff-Legged Gait: Benign Acute Childhood Myositis

personal edition > orthopaedics other > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Considerations in Pharmacy Compounding and the Treatment of Spasticity

Presented by:	The American Society of Health-System Pharmacists
Lecturer	Tamira Mullarkey
Approximate duration:	Not available
Summary points:	This text-only CME activity consists of 2 articles: The first discusses considerations in pharmacy compounding, including the legal and regulatory debate associated with the oversight of pharmacy compounding practices; the second article reviews the treatment of spasticity, with particular emphasis on the use of intrathecal baclofen therapy.
Accreditation:	The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The supplement as a whole provides 1.5 hours (0.15 CEU) of continuing-education credit (program number 204-000-09-004-H01P, knowledgebased activity). Expiration Date: July 1, 2012.
Other:	Text-only CE.

Additional Information